Virologie, the official journal of the French Society of Virology has been indexed Medline/PubMed, since February 2019.
Virologie offers top-level information for all those for whom virology is already the main or an important part of their activity: biologists, clinicians, pharmacists, veterinarians, agronomists, etc.
Made up of review articles written by the best clinicians and researchers in the field, Virology provides detailed data and reports on the latests knowledge, drawing onthe most recent publication in the international literature.
A new section for review articles written in english will be open, the "english e-section of Virologie".
Volume 26, issue 3, Mai-Juin 2022
Point de vueSee full Table of contents >
English e-section of Virologie
You can submit your articles in english
Submit a review article in french and in english
Free open-access publication
Submit your review article in english only
Optional paid open-access
The english reviews are available online only, in the english e-section.
Here you will find all John Libbey Eurotext (JLE) policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.
- Editorial policy
- Peer review policy
- Commercial policy
- Ethical rules - Links of interest, human and animal rights, informed patient consent
- Corrections, retractions and expressions of reservations
- Copyright, Open Access and data sharing
english e-sectionAll articles >
Facing challenges with the novel coronavirus SARS-CoV-2 outbreak
On December 31, 2019, Chinese authorities reported a cluster of pneumonia cases in Wuhan, China, most of which included patients who
reported exposure to a seafood market selling live animals. Emergence of a new pathogenic zoonotic coronavirus (2019-nCoV) was suspected. By the
12th January 2020, several full genomic sequences were made available by Chinese authorities through the Global Initiative on Sharing All Influenza Data (GISAID) public platform [...]